Key result
Left ventricular thrombus in CHF is highly prevalent but linked to low excess thromboembolic risk.
Clinical decisions to treat congestive heart failure patients with oral anticoagulants for left ventricular thrombus must be individualized due to a lack of reliable clinical risk indicators.
May warrant individualized anticoagulation decisions for LV thrombus in HF; leaves open need for better risk indicators and RCTs.
Left ventricular thrombus is highly prevalent in patients with congestive heart failure, but the increase of thromboembolic events is low. Reliable clinical indicators of increased thromboembolic risk are not yet available. Clinical decisions to treat patients who have congestive heart failure with oral anticoagulants must be made on an individual basis.
No takes yet. Share an insight, caveat, or question.
Stuart D. Katz (1995) studied this question. Left ventricular thrombus is highly prevalent in patients with congestive heart failure but is associated with a low increase in thromboembolic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: